Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-04 · accession 0001104659-25-056578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-05 | 2025-06-04 | ANVS | Maccecchini Maria-Luisa | Pres, CEO, Dir | A - Grant | $3.37 | +46.0K | 1.11M | +4% | +$155.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | A | A | 46,000 | $3.37 | 1,114,459 | D | — | — |